Dec 21, 2021 7:00am EST XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease
Dec 10, 2021 7:01am EST XORTX Therapeutics Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients
Dec 09, 2021 8:03am EST XORTX Announces Research Coverage Initiated by A.G.P./Alliance Global Partners
Nov 09, 2021 7:00am EST XORTX Therapeutics Announces Partial Exercise of Over-Allotment Option Pursuant to US Public Offering
Nov 04, 2021 2:48pm EDT XORTX Therapeutics Clarifies Halt of Trading in Canada and Timing for Commencement of Trading on TSX Venture Exchange
Nov 02, 2021 6:13pm EDT XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange